Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm (COCABIO000)
Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm.
Sponsor: Institut Claudius Regaud
A NA clinical study on Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm, this trial is completed. The trial is conducted by Institut Claudius Regaud and has accumulated 13 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Jan 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Sep 2023 [monthly]
Active Not Recruiting NA
▶ Show 8 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Active Not Recruiting NA
-
Feb 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — Jan 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Nov 2017 [monthly]
Recruiting NA
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut Claudius Regaud
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France , Caen, France , Clermont-Ferrand, France , Le Puy-en-Velay, France , Limoges, France , Marseille, France , Montpellier, France , Quint-Fonsegrives, France , Saint-Herblain, France , Toulouse, France and 1 more location